Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.78/sh
Tweet
Share
E-mailGet Alerts AUPH Hot Sheet
Join SI Premium – FREE
Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.78), versus ($0.17) reported last year.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Morgan Stanley continues to recommend exposure to the broadening theme
- SailPoint completes acquisition of Entro Security
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
